Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_assertion type Assertion NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_head.
- NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_provenance.
- NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_assertion evidence source_evidence_literature NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_provenance.
- NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_assertion SIO_000772 22207187 NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_provenance.
- NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_assertion wasDerivedFrom befree-2016 NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_provenance.
- NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_assertion wasGeneratedBy ECO_0000203 NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_provenance.